Diphlorethohydroxycarmalol inhibits melanogenesis via protein kinase A/cAMP response element-binding protein and extracellular signal-regulated kinase-mediated microphthalmia-associated transcription factor downregulation in α-melanocyte stimulating hormone-stimulated B16F10 melanoma cells and zebrafish.

Abstract

Diphlorethohydroxycarmalol (DPHC) is a marine polyphenolic compound derived from brown alga Ishige okamurae. A previously study has suggested that DPHC possesses strong mushroom tyrosinase inhibitory activity. However, the anti-melanogenesis effect of DPHC has not been reported at cellular level. The objective of the present study was to clarify the melanogenesis inhibitory effect of DPHC and its molecular mechanisms in murine melanoma cells (B16F10) and zebrafish model. DPHC significantly inhibited tyrosinase activity and melanin content dose-dependently in α-melanocyte stimulating hormone (α-MSH)-stimulated B16F10 cells. This polyphenolic compound also suppressed the expression of phosphorylation of cAMP response element-binding protein (CREB) by attenuating phosphorylation of cAMP-dependent protein kinase A, resulting in decreased MITF expression levels. Furthermore, DPHC downregulated MITF protein expression levels by promoting the phosphorylation of extracellular signal-regulated kinase. It also inhibited tyrosinase, tyrosinase-related protein 1 (TRP-1), and TRP-2 in α-MSH stimulated B16F10 cells. In in vivo studies using zebrafish, DPHC also markedly inhibited melanin synthesis in a dose-dependent manner. These results demonstrate that DPHC can effectively inhibit melanogenesis in melanoma cells in vitro and in zebrafish in vivo, suggesting that DPHC could be applied in fields of pharmaceutical and cosmeceuticals as a skin-whitening agent. Significance of study: The present study showed for the first time that DPHC could inhibit a-MSH-stimulated melanogenesis via PKA/CREB and ERK pathway in melanoma cells. It also could inhibit pigmentation in vivo in a zebrafish model. This evidence suggests that DPHC has potential as a skin whitening agent. Taken together, DPHC could be considered as a novel anti-melanogenic agent to be applied in cosmetic, food, and medical industry.

• Authors: Yuling Ding, Yunfei Jiang, Seung Tae Im, Seungwon Myung, Hyun-Soo Kim, Seung-Hong Lee
• Journal: Cell biochemistry and function (Cell Biochem Funct) Vol. 39 Issue 4 Pg. 546-554 (Jun 2021) ISSN: 1099-0844 [Electronic] England
• PMID: 33474761 (Publication Type: Journal Article)
• Copyright: © 2021 John Wiley & Sons Ltd.

Chemical References

• Antineoplastic Agents
• Cyclic AMP Response Element-Binding Protein
• Heterocyclic Compounds, 3-Ring
• Microphthalmia-Associated Transcription Factor
• diphlorethohydroxycarmalol
• alpha-MSH
• Cyclic AMP-Dependent Protein Kinases
• Extracellular Signal-Regulated MAP Kinases

Topics

• Animals
• Antineoplastic Agents (chemistry, isolation & purification, pharmacology)
• Cell Survival (drug effects)
• Cyclic AMP Response Element-Binding Protein (antagonists & inhibitors, metabolism)
• Cyclic AMP-Dependent Protein Kinases (antagonists & inhibitors, metabolism)
• Dose-Response Relationship, Drug
• Down-Regulation (drug effects)
• Drug Screening Assays, Antitumor
• Extracellular Signal-Regulated MAP Kinases (metabolism)
• Heterocyclic Compounds, 3-Ring (chemistry, isolation & purification, pharmacology)
• Melanoma (drug therapy, metabolism, pathology)
• Mice
• Microphthalmia-Associated Transcription Factor (antagonists & inhibitors, metabolism)
• Molecular Structure
• Phaeophyta (chemistry)
• Structure-Activity Relationship
• Tumor Cells, Cultured
• Zebrafish (embryology)
• alpha-MSH (antagonists & inhibitors, metabolism)